Community Health Systems
Community Health Systems' revenue fell 1.2% to $12.5 billion in fiscal 2025. Its operating margin was 11.9%, up from 4.3% a year earlier. Free cash flow was $208 million, up 73.3%. The diluted share count rose 2.2%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
What Community Health Systems does
Community Health Systems is a hospital company. Its subsidiaries operate acute care hospitals and other sites of care in 36 markets across 14 states. At the end of 2025 they owned or leased 69 hospitals with more than 10,000 beds. They also ran more than 1,000 other sites, including physician practices, urgent care centers, freestanding emergency departments, occupational medicine clinics, imaging centers, cancer centers and ambulatory surgery centers.
It earns revenue by providing hospital and outpatient services to patients in the communities where it operates. It is paid by government agencies, private insurers and the patients themselves. Its markets range from communities served by a single hospital to large regional networks.
The 10-K says its hospitals and businesses are owned by separate subsidiaries of the parent company, Community Health Systems, Inc., and the company is working to complete some divestitures, which are sales of hospitals or other operations.
Its biggest risks, as it describes them
- Its debt is large, and several series of its notes and other debt mature close together.
- It may be unable to complete the divestitures it considers advisable.
- Its results have been hurt by tough macroeconomic conditions.
- Payment by government programs and insurers, which pay for much of its care, can change.
Income statement
From fiscal 2020 to 2025, earnings per share fell 3.0% a year and net income 0.1% a year, as new shares raised the share count by 16% and diluted each share's earnings.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 507 | 118 | 38 | 37 | 260 |
| Debt incl. finance leases | 12,381 | 11,858 | 11,703 | 11,647 | 10,599 |
| Net debt (negative means net cash) | 11,874 | 11,740 | 11,665 | 11,610 | 10,339 |
| Net debt to EBITDA | 6.1x | 8.7x | 8.0x | 11.3x | 5.4x |
| Debt to equity | — | — | — | — | — |
| Interest coverage | 1.8x | 1.0x | 1.2x | 0.7x | 1.9x |
| Current ratio | 1.5x | 1.4x | 1.5x | 1.4x | 1.5x |
| Quick ratio | 1.5x | 1.4x | 1.5x | 1.4x | 1.5x |
Cash flow
Projections
Project Community Health Systems' revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
Insider trades
Over the 12 months between November 20, 2025 and November 19, 2026, no insider bought Community Health Systems shares on the open market, and 1 insider sold $118,400.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 25, 2026 | William Norris JenningsDirector | Sold | 40,000 | $2.96 | $118,400 | Form 4 |
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | 5 of 9 | 4 of 9 | 8 of 9 |
| Rule of 40 | 0.2% | 2.1% | 0.5% |
| Altman Z'' | 0.05 | −0.36 | 0.30 |
| Accruals ratio | −2.4% | −7.0% | −0.2% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Fail | Fail | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Fail | Fail | Pass |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Fail | Fail | Pass |
| Current ratio rose | Pass | Fail | Pass |
| Share count didn't rise | Fail | Fail | Fail |
| Gross margin rose | Pass | Pass | Pass |
| Revenue rose relative to assets | Pass | Pass | Pass |
| F-score | 5 of 9 | 4 of 9 | 8 of 9 |
Compare
Put Community Health Systems side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Community Health Systems | FY25 | −1.2% | 11.9% | 1.7% | 14.5% | 5.4x | 8 | |
| Universal Health Services | FY25 | 9.7% | 11.5% | 4.9% | 13.1% | 1.8x | 6 | Compare |
| Tenet Health | FY25 | 3.1% | 16.5% | 11.9% | 18.3% | 2.4x | 6 | Compare |
| Ardent Health | FY25 | 6.0% | — | — | — | — | 6 | Compare |
| Encompass Health | FY25 | 10.5% | — | 7.4% | 15.8% | 1.7x | 8 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 18,438 | 15,353 | 14,155 | 13,210 | 11,789 | 12,368 | 12,211 | 12,490 | 12,634 | 12,485 |
| Revenue growth | — | −16.7% | −7.8% | −6.7% | −10.8% | 4.9% | −1.3% | 2.3% | 1.1% | −1.2% |
| Gross profit | 15,427 | 12,681 | 11,800 | 11,059 | 9,826 | 10,326 | 10,236 | 10,497 | 10,688 | 10,621 |
| Research and development | — | — | — | — | — | — | — | — | — | — |
| Operating income | −860 | −1,878 | 208 | 650 | 1,126 | 1,402 | 821 | 957 | 542 | 1,488 |
| Net income | −1,721 | −2,459 | −788 | −675 | 511 | 230 | 46 | −133 | −516 | 509 |
| Diluted EPS (US$) | −15.54 | −22.00 | −6.99 | −5.93 | 4.39 | 1.76 | 0.35 | −1.02 | −3.90 | 3.77 |
| Diluted shares (millions) | 111 | 112 | 113 | 114 | 116 | 131 | 130 | 130 | 132 | 135 |
| Cash flow | ||||||||||
| Cash from operations | 1,137 | 773 | 274 | 385 | 2,178 | −131 | 300 | 210 | 480 | 543 |
| Capital expenditure | 744 | 564 | 527 | 438 | 440 | 469 | 415 | 467 | 360 | 335 |
| Free cash flow | 393 | 209 | −253 | −53 | 1,738 | −600 | −115 | −257 | 120 | 208 |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 123 | 6 | 26 | 13 | 1 | 3 | 9 | 38 | 25 | 1 |
| Stock-based compensation | 46 | 24 | 13 | 10 | 13 | 25 | 20 | 22 | 17 | 11 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 238 | 563 | 196 | 216 | 1,676 | 507 | 118 | 38 | 37 | 260 |
| Debt incl. finance leases | 15,244 | 13,913 | 13,596 | 13,518 | 12,295 | 12,381 | 11,858 | 11,703 | 11,647 | 10,599 |
| Total assets | 21,944 | 17,450 | 15,859 | 15,609 | 16,006 | 15,217 | 14,669 | 14,455 | 14,054 | 13,204 |
| Total liabilities | 19,662 | 17,615 | 16,818 | 17,248 | 17,060 | 16,027 | 15,403 | 15,279 | 15,371 | 14,041 |
| Shareholders' equity | 1,615 | −767 | −1,535 | −2,218 | −1,625 | −1,372 | −1,367 | −1,392 | −1,914 | −1,394 |
| Margins and ratios | ||||||||||
| Gross margin | 83.7% | 82.6% | 83.4% | 83.7% | 83.3% | 83.5% | 83.8% | 84.0% | 84.6% | 85.1% |
| Operating margin | −4.7% | −12.2% | 1.5% | 4.9% | 9.6% | 11.3% | 6.7% | 7.7% | 4.3% | 11.9% |
| Net margin | −9.3% | −16.0% | −5.6% | −5.1% | 4.3% | 1.9% | 0.4% | −1.1% | −4.1% | 4.1% |
| Free cash flow margin | 2.1% | 1.4% | −1.8% | −0.4% | 14.7% | −4.8% | −0.9% | −2.1% | 0.9% | 1.7% |
| Rule of 40 (growth + FCF margin) | — | −15.4% | −9.6% | −7.1% | 4.0% | 0.1% | −2.2% | 0.2% | 2.1% | 0.5% |
| Return on capital | −3.6% | −10.1% | 1.3% | 4.5% | 11.1% | 10.5% | 4.0% | 4.6% | 4.2% | 14.5% |
| Return on equity | −61.1% | — | — | — | — | — | — | — | — | — |
| Return on assets | −7.1% | −12.5% | −4.7% | −4.3% | 3.2% | 1.5% | 0.3% | −0.9% | −3.6% | 3.7% |
| Net debt to EBITDA | 62.5x | — | 14.8x | 10.6x | 6.3x | 6.1x | 8.7x | 8.0x | 11.3x | 5.4x |